New England Journal of Medicine · 2023 · 49 citations · 10 references
Life SciencesImmunologyOncologyCancer ImmunologyImmunotherapyTumor ImmunologyCancer ImmunotherapyCheckpoint Inhibitor TherapyImmune Checkpoint InhibitorsImmune Checkpoint ModulationImmune Checkpoint RegulationImmune CheckpointsImmune Checkpoint Inhibitor TherapyImmune Checkpoint ReceptorsImmune Checkpoint ResistanceResistance To Checkpoint Inhibitors
Immune checkpoint inhibitors represent a major advance in the treatment of cancer. The authors argue that future efforts should focus less on redundant agents and more on new approaches to immunotherapy.
10
Use of CAR-Transduced Natural Killer Cells in CD19-Positive Lymphoid Tumors
Enli Liu, David Marín, Pinaki P. Banerjee et al. · New England Journal of Medicine · 2020 · 2.1K citations · Full text
Life Sciences, Immunology, Oncology +17
PD-1 Blockade in Mismatch Repair–Deficient, Locally Advanced Rectal Cancer
Andrea Cercek, Melissa Lumish, Jenna Sinopoli et al. · New England Journal of Medicine · 2022 · 1.5K citations · Full text